formoterol fumarate

Trials studying formoterol fumarate

• phase1Bioequivalence Study of Budesonide/Formoterol Inhalation Powder in Healthy Participantscompletedn=30
• phase3Budesonide/Formoterol Inhalation Powder in Adults With Asthmacompletedn=338
• phase4A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflationrecruitingn=56
• phase3Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI)completedn=708
• phase3A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroidcompletedn=1,377
• phase1A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthmarecruitingn=12
• —Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Settingrecruitingn=2,000
• phase3Functional Respiratory Imaging Study (DARWiIN)completedn=25